The conflict between pharmaceutical patents and public health has been a hotly disputed issue in the world.
药品专利与公共健康之争是当前国际上的一个热点问题。
参考来源 - WTO背景下药品专利与公共健康之冲突与协调·2,447,543篇论文数据，部分数据来源于NoteExpress
Chapter Four proposes assumptions on how to perfect compulsory license system of pharmaceutical patents under WTO.
文章第四章针对如何完善WTO框架下的药品专利强制许可机制，提出了一些建议与设想。
Compulsory license of pharmaceutical patents, as the most effective method to promote access to medicines, becomes the focus of the debate.
作为提高药品可获得性最为直接有效的方式，药品专利强制许可被推向了论战的风口浪尖。
Kathleen Jaeger of America's Generic Pharmaceutical Association adds that branded firms try to extend their lucrative monopolies by filing less rigorous secondary patents designed “to block generics”.
美国通用药物协会的Kathleen Jaeger补充说很多品牌药公司制作大量的文件申请专利分案“以阻碍仿制药”。
应用推荐